The rise of cell therapy trials for stroke: review of published and registered studies.
about
The Dark Side of the Force - Constraints and Complications of Cell Therapies for StrokeFate of graft cells: what should be clarified for development of mesenchymal stem cell therapy for ischemic stroke?Review of Preclinical and Clinical Studies of Bone Marrow-Derived Cell Therapies for Intracerebral HemorrhageSafety and Feasibility of Autologous Mesenchymal Stem Cell Transplantation in Chronic Stroke in Indian patients. A four-year follow upDistribution of mesenchymal stem cells and effects on neuronal survival and axon regeneration after optic nerve crush and cell therapy.Stem cell-like dog placenta cells afford neuroprotection against ischemic stroke model via heat shock protein upregulation.Transplantation of Induced Pluripotent Stem Cells Alleviates Cerebral Inflammation and Neural Damage in Hemorrhagic Stroke.Surface Phosphatidylserine Is Responsible for the Internalization on Microvesicles Derived from Hypoxia-Induced Human Bone Marrow Mesenchymal Stem Cells into Human Endothelial Cells.Effectiveness and Safety of Autologous Bone Marrow Stromal Cells Transplantation After Ischemic Stroke: A Meta-AnalysisIntraspinal bone-marrow cell therapy at pre- and symptomatic phases in a mouse model of amyotrophic lateral sclerosis.A Detailed Assessment of Varying Ejection Rate on Delivery Efficiency of Mesenchymal Stem Cells Using Narrow-Bore Needles.Cell therapy in Brazil: time for reflection.Stem and Progenitor Cell-Based Therapy of the Central Nervous System: Hopes, Hype, and Wishful Thinking.Radiopharmaceutical stem cell tracking for neurological diseases.Preparing the ground for tissue regeneration: from mechanism to therapy.Understanding and preventing the development of post-stroke dementia.The next revolution in stroke care.Stem cell transplantation enhances endogenous brain repair after experimental stroke.Bone Marrow-Derived Cells as a Therapeutic Approach to Optic Nerve Diseases.Adenosine production: a common path for mesenchymal stem-cell and regulatory T-cell-mediated immunosuppression.Inflammation and Stroke: An OverviewInsights into cell-free therapeutic approach: Role of stem cell "soup-ernatant".The effect of injection using narrow-bore needles on mammalian cells: administration and formulation considerations for cell therapiesIntra-arterial transplantation of low-dose stem cells provides functional recovery without adverse effects after stroke.Age of donor of human mesenchymal stem cells affects structural and functional recovery after cell therapy following ischaemic stroke.Cell Therapy in Stroke-Cautious Steps Towards a Clinical Treatment.A biomaterials approach to influence stem cell fate in injectable cell-based therapies.Translational considerations in injectable cell-based therapeutics for neurological applications: concepts, progress and challenges.Stem Cell Therapy and Administration Routes After Stroke.Mesenchymal stem cell transplantation as an effective treatment strategy for ischemic stroke in Asia: a meta-analysis of controlled trials.Spatiotemporal Protein Atlas of Cell Death-Related Molecules in the Rat MCAO Stroke Model
P2860
Q26800181-CBB87F45-D63E-4B4C-99A5-ED0C7F61866BQ27692601-FA75293F-C3C0-4A3D-8B62-D4086FBF7218Q28079830-EC568A83-9FE7-440C-BD2B-7C701E15E881Q33863334-CC9210E1-23C4-4590-9BF3-3D79D0175E2FQ34408378-67FC4847-F677-4FFB-9A2C-0D2935C2BA0EQ35006313-D36EA834-27E7-4A30-85A8-ECB15629FA3AQ35667418-6DE8A192-454F-474A-9B9B-C396E26D2193Q35903711-4CCA66C5-D79B-4CF7-9124-29F3069AE100Q35910972-1294996A-AA9D-4A86-97E4-9557D3BF79E0Q36686895-F99A6066-747C-4594-8EBC-4E7285860031Q36728564-677AE38F-6AB0-4B94-BCA0-407F6343A10EQ37320694-2C6EBAD5-7146-444A-A1B6-A8A42195CEAFQ37643268-9749809B-647C-43F4-A678-0C6E81B6D481Q38225145-BE7B4760-9F97-4343-AF2E-B24F9C6DCCEEQ38237617-CA026BE4-F772-4105-8C12-4FE389432464Q38238144-98C61285-DF4E-43E8-80BB-814E30254874Q38261542-1F9879F0-97A9-43CD-A31A-6ED9511C5E7DQ38369063-E73BBB0D-02DC-4A64-9126-CAA9F655AA7EQ38663476-166F02BC-A34B-4C65-9A9B-C6D4306CE546Q38936385-5431D510-051D-47BD-AC13-FB804F0F3DD4Q38978527-B3CFAB72-8835-4206-A493-6248F68366C9Q39189306-87F2483F-86E3-4B34-8CD9-BBAD8CF1C5CAQ42396489-AC9A7ABA-6B67-4661-B64B-C6A013C71A12Q44014320-523609AE-4036-4335-BFC3-822F1159C211Q47797257-91694062-C2EC-4F77-812F-280AAF19F276Q47833142-1D510522-0C1E-4F00-8030-64CBBAF54245Q50356780-3735D0D5-139F-42B1-BA2A-E8C5A0FFE42EQ53476373-B2DF4558-4F85-48D2-B462-5C5832BA4E44Q54015446-66B8CE7B-BFAC-4112-85E2-2F640265B806Q55004553-289FC6A3-DEF9-4667-9281-84201F3B45E2Q58772968-841477BC-24AD-4BBF-B3D9-A433E93AF6D6
P2860
The rise of cell therapy trials for stroke: review of published and registered studies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The rise of cell therapy trials for stroke: review of published and registered studies.
@en
The rise of cell therapy trials for stroke: review of published and registered studies.
@nl
type
label
The rise of cell therapy trials for stroke: review of published and registered studies.
@en
The rise of cell therapy trials for stroke: review of published and registered studies.
@nl
prefLabel
The rise of cell therapy trials for stroke: review of published and registered studies.
@en
The rise of cell therapy trials for stroke: review of published and registered studies.
@nl
P2093
P2860
P356
P1476
The rise of cell therapy trials for stroke: review of published and registered studies.
@en
P2093
Gabriel Rodriguez de Freitas
Lea Mirian Barbosa da Fonseca
Paulo Henrique Rosado-de-Castro
Pedro Moreno Pimentel-Coelho
Rosalia Mendez-Otero
P2860
P304
P356
10.1089/SCD.2013.0089
P577
2013-04-25T00:00:00Z